Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The peptide does not appear to bind a single dedicated receptor
This process strengthens the skins internal support structure, helping it stay firm and resilient as volume shifts occur
It changes the concentration of the solution, which changes how many units you draw
Research-grade specs Components: GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) + KPV (10 mg) Total strength: 80 mg per vial Format: Lyophilized powder, single-vial blend Pathways studied: Matrix remodelling (GHK-Cu), cell migration (BPC-157, TB-500), cytokine signalling (KPV) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Receptor and cytokine pathway interaction research Copper-peptide and tripeptide comparative research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
Retatrutide does not require cycling based on current clinical trial data, where participants used it continuously for 48 weeks
The prescribing doctor must document medical justification for the compounded version, such as a patient's need for a specific dose, strength, or formulation unavailable commercially
